智能AI
morning
OpenAI 收购 Orchestra Bio
摘要
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
OpenAI
acquiring
Orchestra
Bio
bring
powered
operations
life
sciences
helping
2026-10-21
1 阅读
约1分钟阅读
OpenAI博客
字号:
OpenAI 正在收购 Orchestra Bio，将人工智能驱动的操作引入生命科学研发，帮助生物制药团队加速药物开发并推进新疗法。
这篇文章对您有帮助吗？
订阅66必读
每日精选科技资讯，直达你的邮箱